Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methaqualone-diphenhydramine interaction study in humans.

K W Hindmarsh, S M Wallace, C B Schneider

    Journal of Pharmaceutical Sciences
    |February 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The potential of salivary biomarkers of nutritional status and dietary intake: A Systematic Review.

    Journal of dentistry·2021
    Same author

    Selection of the family physician.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Medication info.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Is the MIC useful in deciding to treat endocarditis surgically?

    International journal of antimicrobial agents·2004
    Same author

    A general screening method for acidic, neutral, and basic drugs in whole blood using the Oasis MCX column.

    Journal of analytical toxicology·2002
    Same author

    Absolute bioavailability and stereoselective pharmacokinetics of doxepin.

    Xenobiotica; the fate of foreign compounds in biological systems·2002

    Diphenhydramine does not affect methaqualone blood levels or its metabolite when taken together. This study found no significant differences in methaqualone pharmacokinetics across different formulations.

    Area of Science:

    • Pharmacology
    • Drug Metabolism
    • Clinical Pharmacokinetics

    Background:

    • Methaqualone and diphenhydramine are often combined in pharmaceutical products.
    • Understanding the pharmacokinetic interaction between these drugs is crucial for safe and effective therapeutic use.

    Purpose of the Study:

    • To investigate the effect of diphenhydramine on the pharmacokinetics of methaqualone and its major metabolite.
    • To compare the bioavailability of methaqualone from different formulations when co-administered with diphenhydramine.

    Main Methods:

    • Healthy subjects received single oral doses of methaqualone alone or with diphenhydramine.
    • Blood samples were collected over 48 hours post-dose.
    • Methaqualone and its metabolite concentrations were quantified using analytical methods.

    Related Experiment Videos

    Main Results:

    • No significant differences in methaqualone peak blood concentrations, area under the curve, or elimination half-life were observed between treatments.
    • Diphenhydramine did not alter methaqualone or its metabolite blood levels.
    • No significant differences in methaqualone bioavailability were detected between the tested commercial formulations.

    Conclusions:

    • Diphenhydramine, at the tested dosage, does not significantly impact methaqualone pharmacokinetics or its metabolite levels.
    • The co-administration of diphenhydramine does not alter methaqualone bioavailability from common pharmaceutical formulations.